NCT07572955 · Mayo Clinic
A Study Of Acute Decompensated Heart Failure
What this study is about
The purpose of this study is to examine shorter hospitalization length as well as a reduced rates of recurrent heart failure hospitalization compared to current the usual treatment in Acute Decompensated Heart Failure. A 1-day reduction in hospital length of stay in unblinded subjects receiving daily HF-FOCUS examinations compared to a blinded the usual treatment treatment group$1.
View original scientific description
The purpose of this study is to examine shorter hospitalization length as well as a reduced rates of recurrent heart failure hospitalization compared to current standard of care in Acute Decompensated Heart Failure. A 1-day reduction in hospital length of stay in unblinded subjects receiving daily HF-FOCUS examinations compared to a blinded standard of care arm.
Interventions
DIAGNOSTIC_TEST
Lung Ultrasound
Patients will undergo lung ultrasound assessments at hospital admission, daily throughout admission, and at hospital discharge.
Primary outcome measures
Number of days in the hospital
Time frame: Baseline
The number of days a patient is in the hospital will be determined by the day of admission and day of discharge. The day of discharge will be defined as when the consultant physician states that the patient is medically ready for discharge from the hospital.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Subjects ≥18 years of age
- Admitted to St. Mary's Hospital Cardiology Progressive Care Unit (Cardiology 1-5 teams)
- Admission diagnosis of either:
- Acute systolic heart failure
- Acute on chronic systolic heart failure
- Acute diastolic heart failure
- Acute on chronic diastolic heart failure
- Acute right heart failure
- Acute on chronic right heart failure
- Failure heart biventricular
- Able to provide informed consent and willing to undergo daily lung ultrasound examinations during their hospitalization.
Exclusion criteria
- Subjects \<18 years of age
- Unable to provide informed consent.
- Unwilling to undergo daily lung ultrasound examinations.
Where
- Rochester, Minnesota
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Sep 8, 2026 · Source of record for eligibility and locations